Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
2010
Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications
2016
Depression
2018 Standout
No health without mental health
2007 Standout
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Dasatinib
2009
Acute kidney injury
2012 Standout
Hepsin promotes prostate cancer progression and metastasis
2004
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
2011
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
The Influence of Macromolecular Crowding and Macromolecular Confinement on Biochemical Reactions in Physiological Media
2001 Standout
Evolution of the cancer genome
2012
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
2012
Regulation of chromatin by histone modifications
2011 Standout
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
2013
Building the Connectivity Map of epigenetics: Chromatin profiling by quantitative targeted mass spectrometry
2014
Cancer Metastasis: Building a Framework
2006 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Resources for mental health: scarcity, inequity, and inefficiency
2007 Standout
Renal replacement therapy in acute kidney injury: controversy and consensus
2015
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
2013
The burden of non-communicable diseases in South Africa
2009 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
PRC2 mediated H3K27 methylations in cellular identity and cancer
2015
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
The Structure of the Extracellular Region of Human Hepsin Reveals a Serine Protease Domain and a Novel Scavenger Receptor Cysteine-Rich (SRCR) Domain
2003
Acute kidney injury
2019 Standout
Molecular characterization ofde novoPhiladelphia chromosome-positive acute myeloid leukemia
2012
Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers
2004
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
2005 Standout
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
2015
Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS
2005
Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis*
2008
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
EMT: 2016
2016 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.
1995
Methamphetamine toxicity and messengers of death
2009
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays
2003
The PI3K Pathway in Human Disease
2017 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
2002 Standout
The molecular neurobiology of depression
2008 StandoutNature
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia
2012
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
Hyponatremia
2000 Standout
Branhamella catarrhalis: an organism gaining respect as a pathogen
1990 Standout
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
2011
Acute Myeloid Leukemia
2015 Standout
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
2005 Standout
Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
2012
Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
2013
Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease
2006
RUNX1Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
2011
New mutations and pathogenesis of myeloproliferative neoplasms
2011
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Diagnosing and Managing Advanced Chronic Myeloid Leukemia
2015
Genomics of chronic neutrophilic leukemia
2016
Prognostic Significance ofASXL1Mutations in Patients With Myelodysplastic Syndromes
2011
Medical applications of membranes: Drug delivery, artificial organs and tissue engineering
2007
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Adolescence: a foundation for future health
2012 Standout
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy
2004
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
2012
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Medication adherence among HIV+ adults
2002
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
2014
Maximizing the right stuff: The trade-off between membrane permeability and selectivity
2017 StandoutScience
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Works of Thomas Ernst being referenced
Resistance to Targeted Therapy in Chronic Myelogenous Leukemia
2007
Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study
2004
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
2010
Activating CBL mutations are associated with a distinct MDS/MPN phenotype
2012
The Prometheus<sup>®</sup> Device for Extracorporeal Support of Combined Liver and Renal Failure
2005
Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma
2002
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study
2000
PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
2016
Prometheus® – a new extracorporeal system for the treatment of liver failure☆
2003
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status
2014
Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities.
1994
Evidence for long-term neurotoxicity associated with methamphetamine abuse
2000
BACTERIAL TRACHEITIS CAUSED BY BRANHAMELLA CATARRHALIS
1987
Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia
1999
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
2011
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
2009
Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms
2008
EZH2 mutational status predicts poor survival in myelofibrosis
2011